Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 58 | 10 | 72 | 489 | 620 |
| Cost of Goods | 25 | 9 | 324 | 503 | 545 |
| Gross Profit | 33 | 1 | -252 | -15 | 76 |
| Operating Expenses | 6,345 | 10,433 | 6,409 | 5,856 | 6,511 |
| Operating Income | -6,288 | -10,423 | -6,337 | -5,368 | -5,890 |
| Other Income | 147 | 5 | 26 | 33 | 140 |
| Pre-tax Income | -6,141 | -10,418 | -6,311 | -5,334 | -5,750 |
| Income Tax | -9 | 243 | 886 | -1,124 | -758 |
| Net Income Continuous | -6,132 | -10,661 | -7,197 | -4,210 | -4,992 |
| Net Income | $-6,132 | $-10,661 | $-7,197 | $-4,210 | $-4,992 |
| EPS Basic Total Ops | -0.47 | -0.75 | -0.52 | -0.35 | -0.43 |
| EPS Basic Continuous Ops | -0.46 | -0.75 | -0.52 | -0.35 | -0.43 |
| EPS Diluted Total Ops | -0.47 | -0.75 | -0.52 | -0.35 | -0.43 |
| EPS Diluted Continuous Ops | -0.46 | -0.75 | -0.52 | -0.35 | -0.43 |
| EBITDA(a) | $-5,687 | $-9,738 | $-5,660 | $-4,696 | $-5,333 |